{"id":"glutamine-alone","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal tolerance issues"},{"rate":null,"effect":"Hyperammonemia (in hepatic dysfunction)"}]},"_chembl":{"chemblId":"CHEMBL930","moleculeType":"Small molecule","molecularWeight":"146.15"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Glutamine is utilized by immune cells (particularly lymphocytes and macrophages) and enterocytes as a major energy substrate and nitrogen donor for nucleotide synthesis. In critical illness and sepsis, endogenous glutamine production becomes insufficient, and supplementation may preserve gut mucosal integrity, reduce bacterial translocation, and modulate immune responses. This mechanism is particularly relevant in intensive care settings where glutamine depletion is associated with increased infection risk and poor outcomes.","oneSentence":"Glutamine is a conditionally essential amino acid that serves as a primary fuel source for rapidly dividing cells and supports immune function and gut barrier integrity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:23.005Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Sepsis or critical illness (Phase 3 investigation)"}]},"trialDetails":[{"nctId":"NCT06617182","phase":"PHASE2","title":"Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2024-09-30","conditions":"Radiation Enteritis","enrollment":150},{"nctId":"NCT06031012","phase":"PHASE3","title":"Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis","status":"COMPLETED","sponsor":"Air Force Military Medical University, China","startDate":"2023-09-15","conditions":"Mucositis Oral","enrollment":138},{"nctId":"NCT07020754","phase":"PHASE2","title":"Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Radiation Induced Oral Mucositis, Oral Mucositis, Oral Mucositis Due to Radiation","enrollment":84},{"nctId":"NCT07347613","phase":"","title":"Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-01","conditions":"Diabetes","enrollment":450},{"nctId":"NCT07287592","phase":"PHASE3","title":"Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-12-30","conditions":"Neuropathy, Cancer","enrollment":70},{"nctId":"NCT01697930","phase":"PHASE1","title":"A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-09","conditions":"Solid Malignancy, Lymphoma","enrollment":67},{"nctId":"NCT07210450","phase":"PHASE2, PHASE3","title":"Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2023-08-15","conditions":"Pulmonary Artery Pressure, Thalassemia, Non-transfusion Dependent Thalassemia","enrollment":8},{"nctId":"NCT07053761","phase":"PHASE2","title":"A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2025-06-30","conditions":"Radiation - Induced Proctitis","enrollment":124},{"nctId":"NCT04353869","phase":"","title":"Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-11-16","conditions":"Glutamine, Diabetic, Cardiovascular Complications","enrollment":995},{"nctId":"NCT06764420","phase":"NA","title":"Effect of Arginine and Glutamine on Radiation-induced Oral Mucositis: a Trible Blinded Randomized Controlled Clinical Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-05-20","conditions":"Radiation Mucositis, Head and Neck Cancer","enrollment":40},{"nctId":"NCT04233788","phase":"","title":"Metabolic Characterization of Space Occupying Lesions of the Brain","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-09-01","conditions":"Brain Tumor, Glioma, IDH Mutation","enrollment":55},{"nctId":"NCT03263429","phase":"PHASE1, PHASE2","title":"Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2017-08-23","conditions":"Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer","enrollment":29},{"nctId":"NCT05954923","phase":"NA","title":"The Glucagonotropic Effect of Amino Acids in Humans","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2023-09-05","conditions":"Healthy","enrollment":12},{"nctId":"NCT01607879","phase":"PHASE2","title":"Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2014-03","conditions":"Prostate Cancer","enrollment":48},{"nctId":"NCT05934825","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa","status":"UNKNOWN","sponsor":"Andalusian Network for Design and Translation of Advanced Therapies","startDate":"2022-10-26","conditions":"Hidradenitis Suppurativa","enrollment":30},{"nctId":"NCT04471415","phase":"PHASE1, PHASE2","title":"Study to Investigate DRP-104 in Adults With Advanced Solid Tumors","status":"TERMINATED","sponsor":"Dracen Pharmaceuticals, Inc.","startDate":"2020-08-31","conditions":"Advanced Solid Tumor, Non Small Cell Lung Cancer Metastatic","enrollment":61},{"nctId":"NCT04684381","phase":"PHASE4","title":"Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients","status":"COMPLETED","sponsor":"Emmaus Medical, Inc.","startDate":"2021-01-04","conditions":"Sickle Cell Disease, Pharmacokinetics","enrollment":13},{"nctId":"NCT02071862","phase":"PHASE1","title":"Study of the Glutaminase Inhibitor CB-839 in Solid Tumors","status":"COMPLETED","sponsor":"Calithera Biosciences, Inc","startDate":"2014-02","conditions":"Solid Tumors, Triple-Negative Breast Cancer, Non Small Cell Lung Cancer","enrollment":210},{"nctId":"NCT04814602","phase":"EARLY_PHASE1","title":"Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2021-03-30","conditions":"Cirrhosis, Liver","enrollment":11},{"nctId":"NCT04073368","phase":"NA","title":"Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)","status":"COMPLETED","sponsor":"Axcella Health, Inc","startDate":"2018-12-03","conditions":"NAFLD","enrollment":112},{"nctId":"NCT04510181","phase":"NA","title":"Effect of an Amino-Acid-Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms","status":"UNKNOWN","sponsor":"Pekarovics, Susan, MD","startDate":"2020-08-01","conditions":"Fibromyalgia","enrollment":100},{"nctId":"NCT01704664","phase":"NA","title":"Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients","status":"UNKNOWN","sponsor":"Medical University of Bialystok","startDate":"2007-03","conditions":"Gastric Cancer","enrollment":240},{"nctId":"NCT00837902","phase":"NA","title":"Genetic Determinants of Response to Beta Blockade","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2009-01","conditions":"Healthy","enrollment":154},{"nctId":"NCT03720015","phase":"NA","title":"Concurrent Training and Nutritional Management in Cancer","status":"COMPLETED","sponsor":"Universidad Francisco de Vitoria","startDate":"2017-07-20","conditions":"Body Weight Changes","enrollment":1},{"nctId":"NCT03743896","phase":"PHASE4","title":"Transdermal Delivery of Glucosamine to the Synovial Fluid of Male and Female With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Lynk Biotechnologies Pte Ltd","startDate":"2016-05-18","conditions":"Osteoarthritis, Knee","enrollment":240},{"nctId":"NCT03730545","phase":"NA","title":"Effect of Enteral Immunonutrition on Immune, Inflammatory Markers and Nutritional Status in Patients Undergoing Gastrectomy for Gastric Cancer","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2017-01-01","conditions":"Gastric Cancer, Enteral Immunonutrition","enrollment":124},{"nctId":"NCT00772824","phase":"PHASE4","title":"Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients","status":"COMPLETED","sponsor":"Banaras Hindu University","startDate":"2007-12","conditions":"Breast Cancer","enrollment":23},{"nctId":"NCT02283190","phase":"PHASE1","title":"1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Ashkan Emadi","startDate":"2014-04","conditions":"Acute Myeloid Leukemia","enrollment":5},{"nctId":"NCT01577706","phase":"NA","title":"Spectroscopic Imaging at 4T: A Drug Challenge Study","status":"TERMINATED","sponsor":"Mclean Hospital","startDate":"2013-06","conditions":"AOD Effects and Consequences","enrollment":7},{"nctId":"NCT02071927","phase":"PHASE1","title":"Study of the Glutaminase Inhibitor CB-839 in Leukemia","status":"COMPLETED","sponsor":"Calithera Biosciences, Inc","startDate":"2014-03","conditions":"Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL)","enrollment":43},{"nctId":"NCT02772861","phase":"NA","title":"Citrulline Challenge Study for Healthy Subjects in the United Kingdom","status":"COMPLETED","sponsor":"University College, London","startDate":"2011-08","conditions":"Intestinal Diseases","enrollment":20},{"nctId":"NCT00502372","phase":"PHASE1","title":"Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)","status":"TERMINATED","sponsor":"Central Arkansas Veterans Healthcare System","startDate":"2008-12","conditions":"Pressure Ulcers","enrollment":9},{"nctId":"NCT01353638","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis","status":"TERMINATED","sponsor":"Christoph Aufricht","startDate":"2011-04","conditions":"End Stage Renal Disease","enrollment":25},{"nctId":"NCT02024191","phase":"PHASE3","title":"The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Ankara Education and Research Hospital","startDate":"2013-12","conditions":"Peripheral Neuropathy","enrollment":80},{"nctId":"NCT01087658","phase":"PHASE3","title":"Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-02","conditions":"Colorectal Neoplasms","enrollment":200},{"nctId":"NCT01215396","phase":"PHASE1","title":"Impact of Varying Doses of Amino Acids on Exercise, Muscular and Mental Performance","status":"COMPLETED","sponsor":"McMaster University","startDate":"2010-07","conditions":"Psychological Phenomena: Central Fatigue","enrollment":12},{"nctId":"NCT00943020","phase":"PHASE4","title":"Effects of Glutamine on Gastric Emptying","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2009-07","conditions":"Starvation","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1565,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cgroup"],"phase":"phase_3","status":"active","brandName":"glutamine alone","genericName":"glutamine alone","companyName":"Air Force Military Medical University, China","companyId":"air-force-military-medical-university-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glutamine is a conditionally essential amino acid that serves as a primary fuel source for rapidly dividing cells and supports immune function and gut barrier integrity. Used for Sepsis or critical illness (Phase 3 investigation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}